The Neuromuscular Disease Network for Canada


Biobanking Working Group Update

NMD4C is committed to strengthening the biobanking resources available to Canadian neuromuscular researchers. In rare diseases, the availability of biosamples is often limited, which hinders research into disease pathogenesis and mechanisms, and therapy development.

NMD4C is pleased to announce the addition of network collaborator Dr. Jason Karamchandani to the biobanking working group. Dr. Karamchandani is an Associate Professor in the Department of Pathology and a neuropathologist at the Montreal Neurological Institute and Hospital, who brings biobanking experience from his work with the Clinical Biospecimen Imaging and Genetic Repository (C-BIG). Dr. Karamchandani will lead the NMD4C in creating a virtual Canadian biobank, a central catalogue which will contain the neuromuscular samples available for research at the different biobanking sites across Canada.

The NMD4C biobanking group has identified eight biobanks (BDMB-MNM-MA, C-BIG, CHU Dumont Biobank, CIMS, CREATION, Neurobiobank, Pfeffer Lab Biobank) that collect and prepare a variety of samples covering a range of neuromuscular diseases. Each of these sites has provided information about what they collect, and the conditions and policies for researchers to access them. While the virtual biobank catalogue is under development, we have listed the biobanks with a summary of the NMDs covered, samples collected, associated sample data, material transfer agreements in place, context of how samples are used, and contact information on the NMD4C site, which you can access here.

If you know of any biobanks that we have missed or are involved in sample collection yourself and are interested in being listed on the NMD4C site and contributing to the virtual biobank catalogue, please let us know!

Logo_Biobank map

Read next...

JND treatabolome

Treatabolome Project Designed to Shorten Diagnosis-to-Treatment Time for Patients with Rare Diseases

The NMD4C would like to share the publication of a special issue of the Journal of Neuromuscular Disease dedicated to the Treatabolome, a new online database for rare disease and gene-specific treatment information. The special issue includes six systematic reviews contributed by experts on rare neurological disorders.


Neuromuscular Research Funding Announcements From Jesse’s Journey and Muscular Dystrophy Canada

The NMD4C is excited to share recent grant funding announcements from two of our partners, Jesse’s Journey and Muscular Dystrophy Canada. Jesse’s Journey will grant $1.7M toward four promising research projects this year. Muscular Dystrophy Canada (MDC) will invest $400,000 towards seven new research projects through the MDC Neuromuscular Disorder (NMD) Research Grant Competition and through the European Joint Programme on Rare Diseases (EJP RD).

newborn screeningMay

Muscular Dystrophy Canada Announce Phase 2 of Newborn Screening Initiatives with Call for Funding Proposals

MDC is excited to launch Phase 2 of their work with a call for proposals for local newborn screening for SMA initiatives. It is anticipated that these projects will be led by labs or clinicians (or both) and should either focus on setting the lab up for testing or ensuring efficient uptake of policy (i.e., addition of SMA to existing provincial newborn screening panel).

EC Update

Early Career Working Group Update

the NDM4C has created a list of profiles for these members, where you can learn more about their research interests, publications, and where you can find them online. The NMD4C has also launched an early-career Slack channel, and are seeking early career member representation on our work packages.


Read Dr. Louise Moyle’s Early Career Blog

Read the latest early career blog post, from NMD4C member Dr. Louise Moyle. 


Jesse’s Journey Grants $1.7 Million to Duchenne Muscular Dystrophy Research

Jesse’s Journey, Canada’s leader in Duchenne muscular dystrophy funded research, will grant $1.7M toward four promising research projects this year.